FDA Adverse Event
Malfunction
Summary report: N
ADVIA CENTAUR VANCOMYCIN (VANC) ASSAY
MDR report key: 3010362
·
Received March 19, 2013
Report
- Report Number
- 1219913-2013-00051
- Event Type
- Malfunction
- Date Received
- March 19, 2013
- Date of Event
- February 18, 2013
- Report Date
- February 20, 2013
- Manufacturer
- SIEMENS HEALTHCARE DIAGNOSTICS, INC.
- Product Code
- LEH
- PMA / PMN Number
- K951059
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CT, US
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
Additional Manufacturer Narrative · 1
THE CAUSE FOR THE DISCORDANT ADVIA CENTAUR VANCOMYCIN RESULT IS UNKNOWN. QUALITY CONTROLS ARE WITHIN RANGE. NO CONCLUSION CAN BE DRAWN. THE INSTRUMENT IS PERFORMING WITHIN SPECIFICATION. THE IFU IN THE EXPECTED RESULTS SECTION: "AS WITH ALL THERAPEUTIC AGENTS, VANCOMYCIN CONCENTRATIONS MUST BE EVALUATED IN CONJUNCTION WITH THE COMPLETE CLINICAL PROFILE TO PROVIDE EFFECTIVE THERAPY."
Description of Event or Problem · 1
A FALSELY ELEVATED ADVIA CENTAUR VANCOMYCIN RESULT WAS OBTAINED ON A PATIENT SAMPLE AND THE RESULT WAS CONSIDERED DISCORDANT WHEN COMPARED WITH REPEAT SAMPLE TESTING. THERE WAS NO REPORT OF PATIENT TREATMENT BEING PRESCRIBED OR ALTERED AND THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT ADVIA CENTAUR VANCOMYCIN RESULT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 114373 | ADVIA CENTAUR VANCOMYCIN (VANC) ASSAY | VANCOMYCIN IMMUNOASSAY | LEH | SIEMENS HEALTHCARE DIAGNOSTICS, INC. | N/A | 017194 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |